ZA912468B - Use of dermatan sulphate for the prevention and therapy of cerebral aging and of central nervous system functional deficit states - Google Patents

Use of dermatan sulphate for the prevention and therapy of cerebral aging and of central nervous system functional deficit states

Info

Publication number
ZA912468B
ZA912468B ZA912468A ZA912468A ZA912468B ZA 912468 B ZA912468 B ZA 912468B ZA 912468 A ZA912468 A ZA 912468A ZA 912468 A ZA912468 A ZA 912468A ZA 912468 B ZA912468 B ZA 912468B
Authority
ZA
South Africa
Prior art keywords
therapy
prevention
nervous system
central nervous
system functional
Prior art date
Application number
ZA912468A
Other languages
English (en)
Inventor
Rinaldo Del Bono
Del Bono Rinaldo
Gianni Ferrari
Ferrari Gianni
Original Assignee
Mediolanum Farmaceutici Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mediolanum Farmaceutici Srl filed Critical Mediolanum Farmaceutici Srl
Publication of ZA912468B publication Critical patent/ZA912468B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
ZA912468A 1990-04-03 1991-04-03 Use of dermatan sulphate for the prevention and therapy of cerebral aging and of central nervous system functional deficit states ZA912468B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT19924A IT1240615B (it) 1990-04-03 1990-04-03 Impiego del dermatan solfato nella prevenzione e terapia dell'invecchiamento cerebrale e degli stati di deficit funzionale del sistema nervoso centrale

Publications (1)

Publication Number Publication Date
ZA912468B true ZA912468B (en) 1992-01-29

Family

ID=11162380

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA912468A ZA912468B (en) 1990-04-03 1991-04-03 Use of dermatan sulphate for the prevention and therapy of cerebral aging and of central nervous system functional deficit states

Country Status (11)

Country Link
EP (1) EP0450508A3 (it)
JP (1) JPH04234819A (it)
KR (1) KR910018030A (it)
AU (1) AU645071B2 (it)
CA (1) CA2039507A1 (it)
FI (1) FI911567A (it)
IE (1) IE911102A1 (it)
IT (1) IT1240615B (it)
NO (1) NO911298L (it)
PT (1) PT97250A (it)
ZA (1) ZA912468B (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2266239B (en) * 1992-03-25 1996-03-06 Jevco Ltd Wound healing compositions containing chondroitin sulphate oligosaccharides
US5958883A (en) * 1992-09-23 1999-09-28 Board Of Regents Of The University Of Washington Office Of Technology Animal models of human amyloidoses
IT1312107B1 (it) * 1999-05-14 2002-04-04 Umberto Cornelli Glicosaminoglicani aventi peso molecolare medio di 2400 d atti altrattamento della demenza senile

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1208509B (it) * 1985-03-13 1989-07-10 Mediolanum Farmaceutici Srl Processo per la produzione di eparan solfato e dermatan solfato naturali sostanzialmente puri eloro impiego farmaceutico.
IT1214609B (it) * 1985-05-17 1990-01-18 Opocrin Spa Esosaminoglicani solfati depolimerizzati ad attivita'antitrombotica, fibrinolitica, antinfiammatoria, loro procedimento di preparazione e composizioni farmaceutiche che li contengono.
IT1213384B (it) * 1986-11-24 1989-12-20 Lab Derivati Organici Mediolan Processo per la preparazione controllata di gilcosaminoglicani a basso peso molecolare.
IT1205042B (it) * 1987-05-28 1989-03-10 Crinos Industria Farmaco Composizione farmaceutica ad attivita' terapeutica per il trattamento della demenza senile di tipo alzheimer
FR2622450B1 (fr) * 1987-11-03 1991-02-22 Sanofi Sa Association heparine/dermatane sulfate

Also Published As

Publication number Publication date
AU7405391A (en) 1991-10-10
JPH04234819A (ja) 1992-08-24
KR910018030A (ko) 1991-11-30
FI911567A0 (fi) 1991-04-02
FI911567A (fi) 1991-10-04
CA2039507A1 (en) 1991-10-04
IT9019924A1 (it) 1991-10-03
AU645071B2 (en) 1994-01-06
IT9019924A0 (it) 1990-04-03
IT1240615B (it) 1993-12-17
IE911102A1 (en) 1991-10-09
EP0450508A3 (en) 1992-11-25
EP0450508A2 (en) 1991-10-09
NO911298D0 (no) 1991-04-03
NO911298L (no) 1991-10-04
PT97250A (pt) 1992-01-31

Similar Documents

Publication Publication Date Title
IL117229A0 (en) Pyrazolopyrimidines and pyrrolopyrimidines for treatment of neuronal and other disorders
HUP9900508A3 (en) Use of 4-amino-4-(4-fluorobenzylamino)-1-ethoxy-carbonylaminobenzene for prophylaxis and treatment of sequelae of reduced circulation in the brain and neurodegenerative disorders
EP0587789A4 (en) Methods of treating injury to the central nervous system
ZA918129B (en) Safety shower
EP0711168A4 (en) METHOD FOR TREATING VPN APOPTOSE AND RELATED ITEMS
HK36693A (en) Use of ketone derivatives in the treatment of cognitive disorders
DE69435280D1 (de) Phosphodiesterase des menschlichen Gehirns und Screening-Verfahren
GB2281649B (en) Authenticating the identity of an authorised person
EP0714511A4 (en) METHOD FOR DETERMINING AND COMBATING DISTURBANCES OF THE CENTRAL VENEER SYSTEM
EP0450508A3 (en) Use of dermatan sulphate for the prevention and therapy of cerebral aging and of central nervous system functional deficit states
EP0488107A3 (en) Tricyclic benzodiazole analogs and their use in the treatment of cardiovascular disorders
GB9211736D0 (en) Allergic treatment
EP0457671A3 (en) Dipyridamide for the treatment of diseases of the central or peripheral nervous system
ZA947912B (en) Treatment of medical disorders associated with free radical formation
ZA984432B (en) Use of low-molecular-weight heparins for the prevention and treatment of trauma of the central nervous system
ZA908490B (en) Use of arylalkylamides in the treatment of neurodegenerative diseases
EP0893123A4 (en) MEANS OF PREVENTIVE AND CURATIVE TREATMENT OF CONDITIONS RELATED TO DIFFERENT FORMS OF AGING OF THE ORGANISM
ZA884835B (en) Treatment of cerebral disorders
DE68929177T2 (de) Verwendung von Dihydropyridinen zur Vorbeugung und Behandlung cerebraler Durchblutungsstörungen
GR3035528T3 (en) Use of triazine compounds for the treatment of memory and learning disorders
ZA893606B (en) Use of diazepinones for treating disorders of the microcirculation
GB9223953D0 (en) Treatment of eye disorders
IE880441L (en) Treating coronary or cerebral disorders
IL94270A0 (en) Anti-ergotypic t cells for the treatment or prevention of autoimmune diseases and methods of use thereof
GB8916112D0 (en) Treatment of mental disorder